{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T08:56:59Z","timestamp":1762160219366},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1987,7,1]],"date-time":"1987-07-01T00:00:00Z","timestamp":552096000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1987,7]]},"DOI":"10.1007\/bf00210832","type":"journal-article","created":{"date-parts":[[2004,9,3]],"date-time":"2004-09-03T10:14:07Z","timestamp":1094206447000},"page":"285-291","source":"Crossref","is-referenced-by-count":22,"title":["Differential effects of fluphenazine-N-mustard, on calmodulin activity and on D1 and D2 dopaminergic responses"],"prefix":"10.1007","volume":"92","author":[{"given":"J.D.","family":"Winkler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Thermos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1471-4159.1986.tb02850.x","volume":"47","author":"N Amlaiky","year":"1986","unstructured":"Amlaiky N, Caron MG (1986) Identification of the D2-dopamine receptor binding subunit in several mammalian tissues and species by photoaffinity labeling. J Neurochem 47:196?204","journal-title":"J Neurochem"},{"key":"CR2","first-page":"937","volume":"12","author":"EL Anderson","year":"1962","unstructured":"Anderson EL, Bellinzona CB, Craig PN, Jaffe GE, Janeway KP, Kaiser C, Lester BM, Nikawitz EJ, Pavloff AM, Reiff HE, Zirkle CL (1962) Synthesis of phenothiazines: 10-piperazinylalkyl derivatives of 2-chloro- and 2-trifluoromethylphenothiazine. Arzneimittelforschung 12:937?942","journal-title":"Arzneimittelforschung"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0024-3205(85)90541-7","volume":"37","author":"J Arnt","year":"1985","unstructured":"Arnt J (1985) Hyperactivity induced by stimulation of separate dopamine D-1 and D-2 receptors in rats with bilateral 6-OHDA lesions. Life Sci 37:717?723","journal-title":"Life Sci"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/BF00428200","volume":"85","author":"J Arnt","year":"1985","unstructured":"Arnt J, Hyttel J (1985) Differential involvement of dopamine D-1 and D-2 receptors in the circling behavior induced by apomorphine, SK&F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats. Psychopharmacology 85:346?352","journal-title":"Psychopharmacology"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1021\/bi00315a002","volume":"23","author":"JL Benovic","year":"1984","unstructured":"Benovic JL, Shorr RGL, Caron MG, Lefkowitz RJ (1984) The mammalian beta2-adrenergic receptor: purification and characterization. Biochemistry 23:4510?4518","journal-title":"Biochemistry"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/0024-3205(84)90540-X","volume":"35","author":"W Billard","year":"1984","unstructured":"Billard W, Ruperto V, Crosby G, Iorio LC, Barnett A (1984) Characterization of the binding of 3H-Sch 23390, a selective D-1 receptor antagonist ligand, in rat striatum. Life Sci 35:1885?1893","journal-title":"Life Sci"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.2042-7158.1980.tb12999.x","volume":"32","author":"B Costall","year":"1980","unstructured":"Costall B, Fortune DH, Granchelli FE, Law SJ, Naylor RJ, Neumeyer JL, Nohria V (1980) On the ability of N-chloroethyl apomorphine derivatives to cause irreversible inhibition of dopamine receptor mechanisms. J Pharmacol 32:571?576","journal-title":"J Pharmacol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0014-2999(85)90549-7","volume":"109","author":"I Creese","year":"1985","unstructured":"Creese I, Chen A (1985) Selective D-1 dopamine receptor increase following chronic treatment with Sch 23390. Eur J Pharmacol 109:127?128","journal-title":"Eur J Pharmacol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1146\/annurev.ne.06.030183.000355","volume":"6","author":"I Creese","year":"1983","unstructured":"Creese I, Sibley DR, Hamblin MW, Leff SE (1983) The classification of dopamine receptors: Relationship to radioligand binding. Annu Rev Neurosci 6:43?71","journal-title":"Annu Rev Neurosci"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1016\/0024-3205(83)90393-4","volume":"32","author":"AJ Cross","year":"1983","unstructured":"Cross AJ, Waddington JL, Ross ST (1983) Irreversible interaction of B-haloalkylamine derivatives with dopamine D-1 and D-2 receptors. Life Sci 32:2733?2740","journal-title":"Life Sci"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1523\/JNEUROSCI.06-08-02352.1986","volume":"6","author":"TM Dawson","year":"1986","unstructured":"Dawson TM, Gehlert DR, McCabe RT, Barnett A, Wamsley JK (1986) D-1 dopamine receptors in the rat brain: a quantitative autoradiographic analysis. J Neurosci 6:2352?2365","journal-title":"J Neurosci"},{"key":"CR12","first-page":"747","volume":"233","author":"ML Dubocovich","year":"1985","unstructured":"Dubocovich ML, Weiner N (1985) Pharmacological differences between the D-2 autoreceptor and the D-1 dopamine receptor in rabbit retina. J Pharmacol Exp Ther 233:747?753","journal-title":"J Pharmacol Exp Ther"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0014-2999(85)90045-7","volume":"110","author":"A Dumbrille-Ross","year":"1985","unstructured":"Dumbrille-Ross A, Niznik H, Seeman P (1985) Separation of Dopamine D-1 and D-2 receptors. Eur J Pharmacol 110:151?152","journal-title":"Eur J Pharmacol"},{"key":"CR14","first-page":"21","volume-title":"Advances in drug research","author":"RF Furchgott","year":"1966","unstructured":"Furchgott RF (1966) The use of beta-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes. In: Harper NJ, Simmonds AB (eds) Advances in drug research. Academic, New York, 3:21?55"},{"key":"CR15","first-page":"27","volume-title":"Symposia in Neuroscience, vol 3: Modulation of central and peripheral transmitter function","author":"DR Gehlert","year":"1986","unstructured":"Gehlert DR, Dawson TM, Barnett A, Yamamura H, Wamsley JK (1986) Autoradiographic localization of dopamine type-1 receptors after labeling with [3H]-Sch 23390 in the rat and human brain: comparison with the distribution of D-2 receptors. In: Biggio G, Spano PF, Toffano G, Gessa GL (eds) Symposia in Neuroscience, vol 3: Modulation of central and peripheral transmitter function. Liviana, Padova, pp 27?35"},{"key":"CR16","first-page":"772","volume":"11","author":"DB Goodale","year":"1985","unstructured":"Goodale DB, Jacobi AGM, Winkler JD, Weiss B (1985) Rapid stereotaxis injections into mouse striatum using a plastic mold. Soc Neurosci 11:772","journal-title":"Soc Neurosci"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/0024-3205(86)90577-1","volume":"38","author":"JM Gorell","year":"1986","unstructured":"Gorell JM, Czarnecki B, Hubbell S (1986) Functional antagonism of D-1 and D-2 dopaminergic mechanisms affecting striatal acetylcholine release. Life Sci 38:2247?2254","journal-title":"Life Sci"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1016\/0006-2952(83)90405-7","volume":"32","author":"MD Hall","year":"1983","unstructured":"Hall MD, Jenner P, Marsden CD (1983) Turnover of specific [3H]spiperone and [3H]N, n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration. J Biochem Pharmacol 32:2973?2977","journal-title":"J Biochem Pharmacol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/0024-3205(83)90423-X","volume":"32","author":"MW Hamblin","year":"1983","unstructured":"Hamblin MW, Creese I (1983) Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline. Life Sci 32:2247?2255","journal-title":"Life Sci"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/277093a0","volume":"277","author":"JW Kebabian","year":"1979","unstructured":"Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93?96","journal-title":"Nature"},{"key":"CR21","first-page":"581","volume":"12","author":"RM Levin","year":"1976","unstructured":"Levin RM, Weiss B (1976) Mechanism by which psychotropic drugs inhibit adenosine cyclic 3?,5?-monophosphate phosphodiesterase of brain. Mol Pharmacol 12:581?589","journal-title":"Mol Pharmacol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0006-2952(78)90233-2","volume":"27","author":"JE Leysen","year":"1978","unstructured":"Leysen JE, Gommeren W, Laduron PM (1978) Spiperone: A ligand of choice for neuroleptic receptors. Biochem Pharmacol 27:307?316","journal-title":"Biochem Pharmacol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265?275","journal-title":"J Biol Chem"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0091-3057(86)90262-5","volume":"25","author":"AG Molloy","year":"1986","unstructured":"Molloy AG, O'Boyle KM, Pugh MT, Waddington JL (1986) Locomotor behaviors in response to new selective D-1 and D-2 dopamine receptor agonists, and the influence of selective antagonists. Pharmacol Biochem Behav 25:249?253","journal-title":"Pharmacol Biochem Behav"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0006-8993(85)90528-1","volume":"329","author":"KA Neve","year":"1985","unstructured":"Neve KA, Loescher S, Marshall JF (1985) Denervation accelerates the reappearance of neostriatal D-2 receptors after irreversible receptor blockade. Brain Res 329:225?231","journal-title":"Brain Res"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0006-8993(81)90234-1","volume":"213","author":"JM Palacios","year":"1981","unstructured":"Palacios JM, Niehoff DL, Kuhar MJ (1981) [3H]spiperone binding sites in brain: Autoradiographic localization of multiple receptors. Brain Res 213:277?289","journal-title":"Brain Res"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/0024-3205(83)90155-8","volume":"33","author":"H Rosengarten","year":"1983","unstructured":"Rosengarten H, Schweitzer JW, Friedhoff AJ (1983) Induction of oral dyskinesias in naive rats by D-1 stimulation. Life Sci 33:2479?2482","journal-title":"Life Sci"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0024-3205(86)90434-0","volume":"39","author":"H Rosengarten","year":"1986","unstructured":"Rosengarten H, Schweitzer JW, Friedhoff AJ (1986) Selective dopamine D-2 receptor reduction enhances a D-1 mediated oral dyskinesia in rats. Life Sci 39:29?35","journal-title":"Life Sci"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0014-2999(85)90435-2","volume":"109","author":"CF Saller","year":"1985","unstructured":"Saller CF, Salama AI (1985) Dopamine receptor subtypes: in vivo biochemical evidence for functional interaction. Eur J Pharmacol 109:297?300","journal-title":"Eur J Pharmacol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1016\/0024-3205(82)90679-8","volume":"31","author":"B Scatton","year":"1982","unstructured":"Scatton B (1982) Further evidence for the involvement of D-2 but not D-1 dopamine receptors in dopaminergic control of striatal cholinergic transmission. Life Sci 31:2883?2890","journal-title":"Life Sci"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0014-2999(78)90148-6","volume":"50","author":"PE Setler","year":"1978","unstructured":"Setler PE, Sarua HM, Zirkle CL, Saunders HL (1978) The central effects of a novel dopamine agonist. Eur J Pharmacol 50:419?430","journal-title":"Eur J Pharmacol"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/294366a0","volume":"294","author":"JC Stoof","year":"1981","unstructured":"Stoof JC, Kebabian JW (1981) Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294:366?368","journal-title":"Nature"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/0024-3205(84)90519-8","volume":"35","author":"JC Stoof","year":"1984","unstructured":"Stoof JC, Kebabian JW (1984) Two dopamine receptors: Biochemistry, physiology. Life Sci 35:2281?2296","journal-title":"Life Sci"},{"key":"CR34","first-page":"3","volume-title":"Symposia in neuroscience, vol 3: Modulation of central and peripheral transmitter function","author":"JC Stoof","year":"1986","unstructured":"Stoof JC, de Vlieger TA, Kebabian JW (1986) Biochemical and physiological manifestations of dopamine receptor stimulation. In: Biggio G, Spano PF, Toffano G, Gessa GL (eds) Symposia in neuroscience, vol 3: Modulation of central and peripheral transmitter function. Liviana, Padova, pp 3?13"},{"key":"CR35","doi-asserted-by":"crossref","unstructured":"Thermos K, Winkler JD, Weiss B (1987) Comparison of the effects of fluphenazine-N-mustard on dopaminergic behavior and dopaminergic binding sites in supersensitive mice. Neuropharmacology (in press)","DOI":"10.1016\/0028-3908(87)90166-3"},{"key":"CR36","first-page":"989","volume":"12","author":"K Thermos","year":"1986","unstructured":"Thermos K, Prozialeck W, Weiss B (1986) Isolation of sites in mouse striatum irreversibly labeled with fluphenazine-N-mustard and apomorphine. Soc Neurosci Abstr 12:989","journal-title":"Soc Neurosci Abstr"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/292463a0","volume":"292","author":"K Tsuruta","year":"1981","unstructured":"Tsuruta K, Frey EA, Grewe CW, Cote TE, Eskay RL, Kebabian JW (1981) Evidence that Ly 141865 specifically stimulates the D-2 dopamine receptor. Nature 292:463?465","journal-title":"Nature"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-201X.1971.tb11000.x","volume":"367","author":"U Ungerstedt","year":"1971","unstructured":"Ungerstedt U (1971) Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 367:69?93","journal-title":"Acta Physiol Scand Suppl"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0005-2744(72)90060-5","volume":"284","author":"P Uzunov","year":"1972","unstructured":"Uzunov P, Weiss B (1972) Separation of multiple molecular forms of cyclic adenosine 3?,5?-monophosphate phosphodiesterase in rat cerebellum by polyacrylamide gel electrophoresis. Biochim Biophys Acta 284:220?226","journal-title":"Biochim Biophys Acta"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0028-3908(73)90061-0","volume":"12","author":"PF Voigtlander Von","year":"1973","unstructured":"Von Voigtlander PF, Moore KE (1973) Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: Effects of apomorphine, l-dopa, amantadine, amphetamine and other psychomotor stimulants. Neuropharmacology 12:451?462","journal-title":"Neuropharmacology"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0003-2697(72)90022-X","volume":"45","author":"B Weiss","year":"1972","unstructured":"Weiss B, Lehne R, Strada S (1972) Rapid microassay of adenosine 3?,5?-monophosphate phosphodiesterase activity. Anal Biochem 45:222?235","journal-title":"Anal Biochem"},{"key":"CR42","first-page":"615","volume":"10","author":"B Weiss","year":"1974","unstructured":"Weiss B, Fertel R, Figlin R, Uzunov P (1974) Selective alteration of the activity of the multiple forms of adenosine 3?,5?-monophosphate phosphodiesterase of rat cerebrum. Mol Pharmacol 10:615?625","journal-title":"Mol Pharmacol"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/B978-0-12-347230-4.50008-1","volume-title":"Calmodulin antagonists and cellular physiology","author":"B Weiss","year":"1985","unstructured":"Weiss B, Sellinger-Barnette M, Winkler JD, Schechter LE, Prozialeck WC (1985) Calmodulin antagonists: Structure-activity relationships. In: Hidaka H, Harshorne DJ (eds) Calmodulin antagonists and cellular physiology. Academic, New York, pp 45?61"},{"key":"CR44","first-page":"105","volume-title":"Symposia in neuroscience, vol 3: Modulation of central and peripheral transmitter function","author":"B Weiss","year":"1986","unstructured":"Weiss B, Goodale DB, Seyfried DM, Thermos K, Winkler JD (1986) Modulation of dopaminergic behavioral responses. In: Biggio G, Spano PF, Toffano G, Gessa GL (eds) Symposia in neuroscience, vol 3: Modulation of central and peripheral transmitter function. Liviana, Padova, pp 105?116"},{"key":"CR45","first-page":"242","volume":"238","author":"JD Winkler","year":"1986","unstructured":"Winkler JD, Weiss B (1986) Reversal of supersensitive apomorphine-induced rotational behavior in mice by continuous exposure to apomorphine. J Pharmacol Exp Ther 238:242?247","journal-title":"J Pharmacol Exp Ther"},{"key":"CR46","first-page":"55","volume":"58","author":"DT Wong","year":"1983","unstructured":"Wong DT, Bymaster FP, Reid LR, Fuller RW, Perry KW, Kornfeld EC (1983) Effect of stereospecific D2-dopamine agonist on acetylcholine concentration in corpus striatum of rat brain. J Neurotrans 58:55?67","journal-title":"J Neurotrans"},{"key":"CR47","first-page":"592","volume":"227","author":"NR Zahniser","year":"1983","unstructured":"Zahniser NR, Dubocovich ML (1983) Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]spiperone in striatum. J Pharmacol Exp Ther 227:592?599","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00210832.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00210832\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00210832","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T13:39:43Z","timestamp":1624628383000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00210832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,7]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1987,7]]}},"alternative-id":["BF00210832"],"URL":"https:\/\/doi.org\/10.1007\/bf00210832","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,7]]}}}